MeSH term
Frequency | Condition_Probility | Adult | 44 | 0.0 |
Aged | 19 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Comparative Study | 7 | 0.0 |
Female | 54 | 0.0 |
Humans | 87 | 0.0 |
Immunohistochemistry/methods | 2 | 0.0 |
Locus Coeruleus/metabolism | 2 | 25.0 |
Male | 57 | 0.0 |
Molecular Chaperones/genetics/*metabolism | 2 | 10.0 |
Mutation | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 61 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 43 | 0.0 |
Animals | 12 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Disease Models, Animal | 2 | 0.0 |
Mice | 4 | 0.0 |
*Molecular Chaperones | 41 | 28.0 |
Molecular Sequence Data | 7 | 0.0 |
Mutation/genetics | 6 | 0.0 |
Rats | 5 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Carrier Proteins/*genetics | 24 | 1.0 |
Dystonia Musculorum Deformans/*genetics | 18 | 90.0 |
*Gene Deletion | 5 | 0.0 |
Middle Aged | 30 | 0.0 |
*Mutation | 5 | 0.0 |
Pedigree | 30 | 0.0 |
Globus Pallidus/*physiopathology | 3 | 75.0 |
Severity of Illness Index | 2 | 0.0 |
Treatment Outcome | 2 | 0.0 |
Chromosome Mapping | 12 | 0.0 |
Dystonia Musculorum Deformans/diagnosis/*genetics | 4 | 100.0 |
Genes, Dominant | 3 | 0.0 |
Genetic Markers/genetics | 2 | 0.0 |
Lod Score | 4 | 0.0 |
Neurologic Examination | 5 | 4.0 |
*Phenotype | 5 | 1.0 |
Adolescent | 30 | 0.0 |
Child | 24 | 0.0 |
Chromosome Deletion | 2 | 0.0 |
DNA Mutational Analysis | 11 | 0.0 |
Follow-Up Studies | 3 | 0.0 |
Genetic Predisposition to Disease/genetics | 2 | 0.0 |
Heterozygote Detection | 5 | 0.0 |
*Variation (Genetics) | 3 | 0.0 |
Adenosine Triphosphate/metabolism | 2 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Base Sequence | 5 | 0.0 |
Molecular Chaperones/*genetics | 3 | 13.0 |
Age Factors | 3 | 0.0 |
Dystonia/*genetics | 4 | 17.0 |
Botulinum Toxins/therapeutic use | 2 | 40.0 |
Carrier Proteins/*genetics/*metabolism | 2 | 2.0 |
Endoplasmic Reticulum/metabolism | 3 | 1.0 |
Immunohistochemistry | 4 | 0.0 |
Torticollis/*genetics | 2 | 50.0 |
Blotting, Northern | 2 | 0.0 |
Child, Preschool | 13 | 0.0 |
Cytoskeletal Proteins/*genetics | 2 | 1.0 |
Dystonic Disorders/*genetics | 3 | 33.0 |
Infant | 4 | 0.0 |
Membrane Glycoproteins/*genetics | 2 | 0.0 |
Myoclonus/*genetics | 2 | 22.0 |
Sarcoglycans | 2 | 8.0 |
Syndrome | 2 | 0.0 |
Age of Onset | 16 | 1.0 |
Polymerase Chain Reaction | 5 | 0.0 |
*Polymorphism, Genetic | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Sequence Deletion | 7 | 0.0 |
Genotype | 12 | 0.0 |
Italy | 2 | 0.0 |
Phenotype | 12 | 0.0 |
Point Mutation/*genetics | 5 | 1.0 |
GTP Cyclohydrolase/genetics | 2 | 20.0 |
Molecular Chaperones/genetics | 2 | 9.0 |
Dystonia Musculorum Deformans/*genetics/physiopathology | 3 | 100.0 |
Carrier Proteins/genetics | 6 | 1.0 |
COS Cells | 2 | 0.0 |
Cell Line | 3 | 0.0 |
Transfection | 3 | 0.0 |
Genetic Counseling | 2 | 1.0 |
*Genetic Screening | 2 | 1.0 |
Jews/*genetics | 5 | 3.0 |
Predictive Value of Tests | 2 | 0.0 |
Alleles | 5 | 0.0 |
Chromosomes, Human, Pair 9/genetics | 5 | 4.0 |
*Founder Effect | 3 | 2.0 |
Haplotypes | 9 | 0.0 |
Jews/genetics | 9 | 10.0 |
*Sequence Deletion | 2 | 0.0 |
Cohort Studies | 2 | 0.0 |
France | 2 | 0.0 |
Prospective Studies | 3 | 0.0 |
*Chromosomes, Human, Pair 9 | 13 | 5.0 |
*Linkage (Genetics) | 4 | 0.0 |
Exons/genetics | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
Dystonia Musculorum Deformans/genetics | 4 | 100.0 |
Organ Specificity | 2 | 0.0 |
Dystonia/ethnology/*genetics | 2 | 100.0 |
Heterozygote | 8 | 0.0 |
Jews | 2 | 2.0 |
Basal Ganglia/metabolism | 3 | 27.0 |
Brain/*metabolism | 2 | 0.0 |
Corpus Striatum/metabolism | 2 | 8.0 |
Thalamus/metabolism | 2 | 28.0 |
Chromosomes, Human, Pair 9 | 5 | 3.0 |
Europe/ethnology | 2 | 2.0 |
Germany | 6 | 1.0 |
Dystonia/*genetics/*physiopathology | 2 | 66.0 |
France/ethnology | 2 | 5.0 |
Gene Deletion | 5 | 0.0 |
Torsion | 2 | 28.0 |
Gene Frequency | 3 | 0.0 |
*Linkage Disequilibrium | 2 | 1.0 |
Mutation/*genetics | 2 | 0.0 |
Point Mutation/genetics | 2 | 0.0 |
Genetic Markers | 8 | 0.0 |
Linkage (Genetics) | 12 | 0.0 |
Tomography, Emission-Computed | 2 | 1.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
*Chromosomes, Human, Pair 8 | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Polymorphism, Genetic | 5 | 0.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
DNA/analysis | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Genes, Dominant/genetics | 2 | 1.0 |
Carrier Proteins/genetics/*metabolism | 2 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Pregnancy | 2 | 0.0 |
Linkage (Genetics)/genetics | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Tuberous Sclerosis/genetics | 2 | 7.0 |
Chromosome Mapping/methods | 2 | 1.0 |
Dystonia Musculorum Deformans/genetics/physiopathology | 2 | 100.0 |
Carrier Proteins/*genetics/metabolism | 2 | 0.0 |
Autoradiography | 2 | 0.0 |
Dopamine/analysis/*metabolism | 2 | 33.0 |
Family Health | 2 | 0.0 |
*Neuropeptides | 2 | 1.0 |
Genetic Screening | 2 | 0.0 |